1st Quarter - Report
W STRATEGIES, LLC for SUPERNUS PHARMACEUTICALS FKA SAGE THERAPEUTICS
Firm
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Education and awareness of mental health issues especially as it relates to access for postpartum depression treatment and major depressive disorder.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.